PSYCHIATRY
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
A Molecular Link between the Active Component of Marijuana and Alzheimer’s Disease
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
The role of inflammation in Alzheimer’s disease
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review
Cannabinoid pharmacology and therapy in gut disorders
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.
Dear Valued Customer,
Given the evolving COVID-19 situation across the country, CannTrust is acting in accordance with the guidance for social distancing, where possible. Our customer service department remains open, but due to a reduction in on-site staff you may experience a delay in our response time. As we deal with a critical situation, the safety of our patients, employees, partners, and community at large is of utmost importance for us.
We thank you for your understanding and we hope to return to regular service levels as soon as possible.